Last reviewed · How we verify

NCT05486364: DIGITOTAL

DIGITal mOnitoring afTer Af abLation

Completed NA Last updated 27 October 2023
What this trial tests

NA trial testing Digital Monitoring in Atrial Fibrillation in 100 participants. Completed in 15 August 2023.

Timeline
20 December 2021
Primary endpoint
1 July 2023
15 August 2023

Quick facts

Lead sponsorZiekenhuis Oost-Limburg
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment100
Start date20 December 2021
Primary completion1 July 2023
Estimated completion15 August 2023
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Ziekenhuis Oost-Limburg — full company profile →

Who can join

18 and older, any sex, with Atrial Fibrillation or Atrial Fibrillation Recurrent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recurrence of atrial fibrillation (AF) after a pulmonary vein isolation (PVI) procedure is frequent. Current follow up with Holter monitoring and electrocardiograms (ECG) during outpatient clinic consultations cover only short time stretches and require hospital visits. Mobile health solutions with rhythm monitoring using photoplethysmography (PPG) technology on a smartphone could extend rhythm monitoring time, while lowering hospital visits and cost. This study aims to compare the performance of a digital health solution using PPG technology on a smartphone versus the current standard of care to monitor for AF recurrence after a PVI procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Ziekenhuis Oost-Limburg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05486364.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing